Table 4 Classification of the subset of healthy and PDAC samples using PancRISK and CA19-9 cut-off of 37 U/mL.

From: Development of PancRISK, a urine biomarker-based risk score for stratified screening of pancreatic cancer patients

Healthy (n = 91)

CA19-9 < 37 U/mL

CA19-9 ≥ 37 U/mL

Specificity: 0.96

PancRISK = “Normal”

87

3

 

PancRISK = “Abnormal”

1

0

 

PDAC (n = 150)

CA19-9 < 37 U/mL

CA19-9 ≥ 37 U/mL

Sensitivity: 0.96

PancRISK = “Normal”

6

30

 

PancRISK = “Abnormal”

15

99

 
Back to article page